Table 4 Outcomes of DPP-4i use, N = 105
From: Dipeptidyl Peptidase-4 inhibitors use in type II diabetic patients in a tertiary hospital
Parameters | Pre DPP-4i use | Post DPP-4i use | Mean difference (95% CI) | p value£ |
|---|---|---|---|---|
HbA1c (%) | 8.5 ± 1.8 | 7.6 ± 1.7 | − 0.90 (− 1.22, − 0.58) | < 0.0001* |
FBG (mmol/L) | 9.2 ± 3.8 | 8.0 ± 3.2 | −1.15 (− 1.80, − 0.51) | 0.001* |
Weight (kg) | 78.1 ± 14.5 | 78.1 ± 14.4 | 0.08 (− 0.41,0.57) | 0.745 |
BMI (kg/m2) | 29.5 ± 4.6 | 30.0 ± 7.0 | 0.50 (− 0.51,1.51) | 0.332 |